Karpen, Saul J.

Gastrointestinal Symptoms in Autism Spectrum Disorder: A Meta-analysis

McElhanon, B. O., McCracken, C., Karpen, S., & Sharp, W. G. (2014) · Pediatrics

Autism Spectrum Disorder ResearchChild Nutrition and Feeding Issues

Cited by 831

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology

Liver Disease Diagnosis and TreatmentDrug Transport and Resistance Mechanisms

Cited by 634

Intestinal transport and metabolism of bile acids

Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research

Drug Transport and Resistance MechanismsGut microbiota and health

Cited by 598

Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet–fed mice

Rao, A., Kosters, A., Mells, J. E., Zhang, W., Setchell, K. D. R., Amanso, A. M., Wynn, G. M., Xu, T., Keller, B. T., Yin, H., et al. (2016) · Science Translational Medicine

Liver Disease Diagnosis and TreatmentDrug Transport and Resistance Mechanisms

Cited by 211

Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats

Sturm, E., Havinga, R., Baller, J. F. W., Wolters, H., van Rooijen, N., Kamps, J. A. A. M., Verkade, H. J., Karpen, S. J., & Kuipers, F. (2005) · Journal of Hepatology

Drug Transport and Resistance MechanismsLiver physiology and pathology

Cited by 60

Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases

Arrese, M., & Karpen, S. J. (2010) · Clinical Pharmacology & Therapeutics

Nuclear Receptors and SignalingLiver physiology and pathology

Cited by 54

The new therapeutic frontier--nuclear receptors and the liver

Karpen, S. J., & Trauner, M. (2010) · Journal of Hepatology

Liver physiology and pathologyPeroxisome Proliferator-Activated Receptors

Cited by 29